UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Analysis and evaluation of graded-index fiber lenses

Journal of lightwave technology, 1987-09, Vol.5 (9), p.1156-1164

1987

Volltextzugriff (PDF)

Polarisation-insensitive coherent receiver using a double balanced optical hybrid system

Electronics letters, 1987-10, Vol.23 (22), p.1195-1196

1987

Volltextzugriff (PDF)

Multiport polarization monitor

Optics letters, 1983-02, Vol.8 (2), p.94

1983

Volltextzugriff (PDF)

Optical coupling between single-mode semiconductor lasers and strip waveguides

Journal of lightwave technology, 1983-06, Vol.1 (2), p.436-443

Emkey, W.

1983

Volltextzugriff (PDF)

Packaging of a polarization independent optical isolator

1991 Proceedings 41st Electronic Components & Technology Conference, 1991, p.157-160

1991

Volltextzugriff (PDF)

Photoconductivity Due to Excitonic-Energy Transfer to Crystalline Defects

Physical review. B, Solid state, 1972-01, Vol.5 (2), p.610-617

1972

Volltextzugriff (PDF)

Thermal dissociation of photoproduced excitons at the uv band edge in NaI

Physical review. B, Condensed matter, 1979-01, Vol.20 (12), p.5326-5329

1979

Volltextzugriff (PDF)

Anisotropic intrinsic photoluminescence in NaI

Journal of the Optical Society of America (1930), 1976-03, Vol.66 (3), p.264

1976

Volltextzugriff (PDF)

Small group approach to introductory physics

American journal of physics, 1979-08, Vol.47 (8), p.695-697

Emkey, William L.

1979

Volltextzugriff (PDF)

An individualized laboratory system

American journal of physics, 1978-01, Vol.46 (1), p.60-62

Emkey, William L.

1978

Volltextzugriff (PDF)

Stimulated luminescence of KI single crystals

Physical review. B, Condensed matter, 1981-01, Vol.23 (4), p.1709-1712

1981

Volltextzugriff (PDF)

Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)

Current medical research and opinion, 2005-12, Vol.21 (12), p.1895-1903

2005

Volltextzugriff (PDF)

Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial

Annals of internal medicine, 2002-12, Vol.137 (11), p.875

2002

Volltextzugriff (PDF)

Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s)

Psychopharmacology, 2005-04, Vol.179 (1), p.271-283

2005

Volltextzugriff (PDF)

An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis

The Journal of pharmacology and experimental therapeutics, 2017-01, Vol.360 (1), p.117-128

2017

Volltextzugriff (PDF)

Alendronate and estrogen effects in postmenopausal women with low bone mineral density

The journal of clinical endocrinology and metabolism, 2000-02, Vol.85 (2), p.720-726

2000

Volltextzugriff (PDF)

Discovery and Optimization of a Novel Series of N-Arylamide Oxadiazoles as Potent, Highly Selective and Orally Bioavailable Cannabinoid Receptor 2 (CB2) Agonists

Journal of medicinal chemistry, 2008-08, Vol.51 (16), p.5019-5034

2008

Volltextzugriff (PDF)

Two‐Year Results of Once‐Weekly Administration of Alendronate 70 mg for the Treatment of Postmenopausal Osteoporosis

Journal of bone and mineral research, 2002-11, Vol.17 (11), p.1988-1996

Rizzoli, R

2002

Volltextzugriff (PDF)

Characterization of a novel G‐protein coupled receptor from the parasitic nematode H. contortus with high affinity for serotonin

Journal of neurochemistry, 2003-07, Vol.86 (1), p.255-266

2003

Volltextzugriff (PDF)

Structural modifications of N-arylamide oxadiazoles : Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2

Bioorganic & medicinal chemistry letters, 2008-08, Vol.18 (15), p.4267-4274

2008

Volltextzugriff (PDF)

(211) CB2 agonists reduce carrageenan-induced thermal hyperalgesia and edema in mice via a non-CB2 receptor mechanism

The journal of pain, 2008, Vol.9 (4), p.28-28

2008

Volltextzugriff (PDF)

Risedronate therapy prevents corticosteroid‐induced bone loss : A twelve‐month, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group study

Arthritis and rheumatism, 1999-11, Vol.42 (11), p.2309-2318

1999

Volltextzugriff (PDF)

Discovery of α-amidosulfones as potent and selective agonists of CB2 : Synthesis, SAR, and pharmacokinetic properties

Bioorganic & medicinal chemistry letters, 2009, Vol.19 (1), p.31-35

2009

Volltextzugriff (PDF)

Corrigendum to “Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2” [Bioorg. Med. Chem. Lett. 18 (2008) 4267–4274]

Bioorganic & medicinal chemistry letters, 2009-01, Vol.19 (1), p.284

2009

Volltextzugriff (PDF)

Corrigendum to “Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB 2” [Bioorg. Med. Chem. Lett. 18 (2008) 4267–4274]

Bioorganic & medicinal chemistry letters, 2009, Vol.19 (1), p.284-284

2009

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(36)
Tagungsberichte
(1)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Humans
(15)
Life Sciences & Biomedicine
(13)
Biological And Medical Sciences
(12)
Medical Sciences
(11)
Physical Sciences
(11)
Pharmacology. Drug Treatments
(10)
Female
(8)
Physics
(8)
Animals
(7)
Double-Blind Method
(7)
Middle Aged
(7)
Adult
(6)
Aged
(6)
Bones, Joints And Connective Tissue. Antiinflammatory Agents
(6)
Pharmacology & Pharmacy
(5)
Technology
(5)
Aged, 80 And Over
(4)
Arthritis, Rheumatoid - Drug Therapy
(4)
Interferon-Gamma - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Analysis and evaluation of graded-index fiber lenses

Polarisation-insensitive coherent receiver using a double balanced optical hybrid system

Multiport polarization monitor

Optical coupling between single-mode semiconductor lasers and strip waveguides

Packaging of a polarization independent optical isolator

Photoconductivity Due to Excitonic-Energy Transfer to Crystalline Defects

Thermal dissociation of photoproduced excitons at the uv band edge in NaI

Anisotropic intrinsic photoluminescence in NaI

Small group approach to introductory physics

An individualized laboratory system

Stimulated luminescence of KI single crystals

Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)

Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial

Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s)

An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis

Alendronate and estrogen effects in postmenopausal women with low bone mineral density

Discovery and Optimization of a Novel Series of N-Arylamide Oxadiazoles as Potent, Highly Selective and Orally Bioavailable Cannabinoid Receptor 2 (CB2) Agonists

Two‐Year Results of Once‐Weekly Administration of Alendronate 70 mg for the Treatment of Postmenopausal Osteoporosis

Characterization of a novel G‐protein coupled receptor from the parasitic nematode H. contortus with high affinity for serotonin

Structural modifications of N-arylamide oxadiazoles : Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2

(211) CB2 agonists reduce carrageenan-induced thermal hyperalgesia and edema in mice via a non-CB2 receptor mechanism

Risedronate therapy prevents corticosteroid‐induced bone loss : A twelve‐month, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group study

Discovery of α-amidosulfones as potent and selective agonists of CB2 : Synthesis, SAR, and pharmacokinetic properties

Corrigendum to “Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2” [Bioorg. Med. Chem. Lett. 18 (2008) 4267–4274]

Corrigendum to “Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB 2” [Bioorg. Med. Chem. Lett. 18 (2008) 4267–4274]

Suchergebnisse filtern